The LDI is among Canada’s leading health research institutes. Through their fundamental and clinical investigations, our scientists and clinicians make significant discoveries, lead important provincial and national research programs, and train emerging scientists who, themselves, are recognized for the excellence of their work, contributing to the health and well-being of patients in Quebec, Canada, and around the world.
At the Lady Davis Institute for Medical Research (LDI), equity, diversity and inclusion are at the heart of who we are. We are committed to provide people working in the LDI community with exemplary, highest quality of work and learning environments that are healthy, equitable and inclusive, free from all forms of discrimination and where every person can feel welcomed and recognized, but also involved and contributing to the present and the future of the LDI.
Discover our 200+ regular and associated investigators and their research, as well as the many services we provide across the spectrum of the research process.
We offer the 250+ graduate and postdoctoral students who come to the LDI each year an open, collaborative, and multidisciplinary training environment that fosters excellence.
The close collaboration between researchers, clinicians, and patients is at the basis of the most successful research programs and clinical trials at the LDI.
At the Lady Davis Institute for Medical Research (LDI), equity, diversity and inclusion are at the heart of who we are. We are committed to provide people working in the LDI community with exemplary, highest quality of work and learning environments that are healthy, equitable and inclusive, free from all forms of discrimination and where every person can feel welcomed and recognized, but also involved and contributing to the present and the future of the LDI.
Une étude de Mark Basik, chercheur principal à @LDI_ILD, met en évidence le rôle d’un nouveau test sanguin qui pourrait aider à déterminer quelles patientes atteintes d’un cancer du sein agressif ont besoin d’une chimiothérapie.
#recherche #cancerdusein
Cutting-edge study highlights the role of a new blood test that may help decide who needs chemotherapy in patients with aggressive triple-negative breast cancer. The research is led by @LDI_ILD Senior Investigator Mark Basik.
#study #research #breastcancer
Le Centre de recherche translationelle sur le cancer de McGill (MCTRC) de l'HGJ à Montréal (Canada) cherche un directeur exécutif à temps plein pour agir comme chef administratif et stratégique du MCTRC. Postulez avant le 13 février 2026
#emploi #direction
The McGill Centre for Translational Research in Cancer at the JGH in Montreal (Canada) is seeking an Executive Director to serve as the senior administrative and strategic leader of the MCTRC. Deadline to apply: February 13, 2026.
#jobs #position #leader